Contact Us
800-701-4624

Ablative therapy using the HALO system

Ablative therapy using the HALO system allows for the treatment of Barrett’s esophagus, a pre-cancerous condition of the esophagus that is commonly caused by chronic esophageal irritation or gastroesophageal reflux disease (GERD). HALO ablation technology uses radio-frequency ablation to destroy Barrett’s cells and diseased tissue in an effort to prevent esophageal cancer. Results from a recent clinical trial published in the new England Journal of Medicine in May 2009, revealed that non-surgical treatment for the pre-cancerous condition of the esophagus, Barrett’s esophagus, is effective and reduces the risk of cancer development.